Sector revisions Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 11:33:45 2025-02-10 am EST			5-day change	1st Jan Change
86.81 ^USD	-0.70%		+2.00%	+5.67%

Feb. 07	Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing	MT
Feb. 05	Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	VERTEX PHARMACEUTICALS INCORPORATED							29
	REGENERON PHARMACEUTICALS, INC.							25
	ARGENX SE							16
	BIONTECH SE							20
	BEIGENE, LTD.							23
	WUXI APPTEC CO., LTD.							17
	INSMED INCORPORATED							16
	NEUROCRINE BIOSCIENCES, INC.							24
	GENMAB A/S							16
	WUXI BIOLOGICS (CAYMAN) INC.							25
	SAREPTA THERAPEUTICS, INC.							20
	EXELIXIS, INC.							22
	AKESO, INC.							18
	MADRIGAL PHARMACEUTICALS, INC.							14
	ASCENDIS PHARMA A/S							15
	ZEALAND PHARMA A/S							11
	PHARMAESSENTIA CORPORATION							5
	Average							19
	Weighted average by Cap.							23

Bio Therapeutic Drugs